These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6320962)

  • 1. Opiate receptor binding-effect relationship: sufentanil and etorphine produce analgesia at the mu-site with low fractional receptor occupancy.
    Rosenbaum JS; Holford NH; Sadée W
    Brain Res; 1984 Jan; 291(2):317-24. PubMed ID: 6320962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discrimination of three types of opioid binding sites in rat brain in vivo.
    Rosenbaum JS; Holford NH; Richards ML; Aman RA; Sadée W
    Mol Pharmacol; 1984 Mar; 25(2):242-8. PubMed ID: 6321946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Buprenorphine: differential interaction with opiate receptor subtypes in vivo.
    Sadée W; Rosenbaum JS; Herz A
    J Pharmacol Exp Ther; 1982 Oct; 223(1):157-62. PubMed ID: 6288917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.
    Richards ML; Sadée W
    Eur J Pharmacol; 1985 Aug; 114(3):343-53. PubMed ID: 2998812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of four types of opioid binding sites in rat brain.
    Sadée W; Richards ML; Grevel J; Rosenbaum JS
    Life Sci; 1983; 33 Suppl 1():187-9. PubMed ID: 6141486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decrease in delta and mu opioid receptor binding capacity in rat brain after chronic etorphine treatment.
    Tao PL; Law PY; Loh HH
    J Pharmacol Exp Ther; 1987 Mar; 240(3):809-16. PubMed ID: 3031275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]Sufentanil, a superior ligand for mu-opiate receptors: binding properties and regional distribution in rat brain and spinal cord.
    Leysen JE; Gommeren W; Niemegeers CJ
    Eur J Pharmacol; 1983 Feb; 87(2-3):209-25. PubMed ID: 6132825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo receptor binding of opioid drugs at the mu site.
    Rosenbaum JS; Holford NH; Sadée W
    J Pharmacol Exp Ther; 1985 Jun; 233(3):735-40. PubMed ID: 2989495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etorphine binds to multiple opiate receptors of the caudate nucleus with equal affinity but with different kinetics.
    Tolkovsky AM
    Mol Pharmacol; 1982 Nov; 22(3):648-56. PubMed ID: 6296657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.
    Perry DC; Rosenbaum JS; Kurowski M; Sadée W
    Mol Pharmacol; 1982 Mar; 21(2):272-9. PubMed ID: 6285166
    [No Abstract]   [Full Text] [Related]  

  • 11. Physical separation of the agonist and antagonist forms of a mu opiate receptor?
    Jauzac P; Puget A; Meunier JC
    Life Sci; 1983; 33 Suppl 1():195-8. PubMed ID: 6319859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of kappa opiate receptors in rat spinal cord-dorsal root ganglion cocultures and their regulation by chronic opiate treatment.
    Attali B; Vogel Z
    Brain Res; 1990 May; 517(1-2):182-8. PubMed ID: 2165432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo binding of benzomorphans to mu, delta and kappa opioid receptors: comparison with urine output in the rat.
    Richards ML; Sadée W
    J Pharmacol Exp Ther; 1985 May; 233(2):425-32. PubMed ID: 2987482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cold-restraint stress reduces [3H]etorphine binding to rat brain membranes: influence of acute and chronic morphine and naloxone.
    Hnatowich MR; Labella FS; Kiernan K; Glavin GB
    Brain Res; 1986 Aug; 380(1):107-13. PubMed ID: 3019462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opiate receptor down-regulation and desensitization in neuroblastoma X glioma NG108-15 hybrid cells are two separate cellular adaptation processes.
    Law PY; Hom DS; Loh HH
    Mol Pharmacol; 1983 Nov; 24(3):413-24. PubMed ID: 6314114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3H-diprenorphine is selective for mu opiate receptors in vivo.
    Frost JJ; Smith AC; Wagner HN
    Life Sci; 1986 Apr; 38(17):1597-606. PubMed ID: 3010021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidural and intravenous sufentanil in the rat: analgesia, opiate receptor binding, and drug concentrations in plasma and brain.
    Colpaert FC; Leysen JE; Michiels M; van den Hoogen RH
    Anesthesiology; 1986 Jul; 65(1):41-9. PubMed ID: 3014923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative film autoradiography of opiate agonist and antagonist binding in rat brain.
    Geary WA; Wooten GF
    J Pharmacol Exp Ther; 1983 Apr; 225(1):234-40. PubMed ID: 6300375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate.
    Kurowski M; Rosenbaum JS; Perry DC; Sadée W
    Brain Res; 1982 Oct; 249(2):345-52. PubMed ID: 6291717
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of [11C]diprenorphine and [11C]carfentanil binding to opiate receptors in humans by positron emission tomography.
    Frost JJ; Mayberg HS; Sadzot B; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Links JM
    J Cereb Blood Flow Metab; 1990 Jul; 10(4):484-92. PubMed ID: 2161414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.